NCT02327741

Efficacy of Long Term Plavix Therapy Post Angioplasty

Evaluation of Safety, Benefits and Complications of Long-term Dual Antiplatelet Therapy in Patients With Angioplasty

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,010 (actual)
• Sponsor: Shiraz University of Medical Sciences · Academic / Other
• Sex: All
• Age: 50 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

1010 patients post stenting were enrolled to receive Plavix more than 12 months and less than that and rate of bleeding, complication and major cardiovascular adverse events ( MACE) were compared to evaluate safety and feasibility of long term Plavix therapy post stenting.

Detailed description

1010 patients from registry of angioplasty and stenting in Shiraz and Baghiatolah hospital were enrolled and long term Plavix therapy more than and less than 12 months were compared between two groups of patients prospectively and rate of major adverse cardiovascular events ( MACE) (death, myocardial infarction, cerebrovascular accidents and revascularization) and rate of bleeding were compared between 2 groups.Syntax score and American heart association ( AHA) score of coronary involvement were measured and MACE was compared to these scores.

Conditions

• Percutaneous Coronary Intervention

Interventions

Type	Name	Description
DRUG	plavix	taking plavix more than 12 months
DRUG	plavix	taking plavix less than 12 months

Timeline

• Start date: 2012-10-01
• Primary completion: 2014-09-01
• Completion: 2014-10-01
• First posted: 2014-12-30
• Last updated: 2020-04-29
• Results posted: 2020-04-29